These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15249226)

  • 1. D-6-Deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, a mimic of d-myo-inositol 1,3,4,5-tetrakisphosphate: biological activity and pH-dependent conformational properties.
    Horne G; Maechling C; Fleig A; Hirata M; Penner R; Spiess B; Potter BV
    Biochem Biophys Res Commun; 2004 Aug; 320(4):1262-70. PubMed ID: 15249226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of inositol 1,4,5-trisphosphate analogues by 3-kinase and dephosphorylation of inositol 1,3,4,5-tetrakisphosphate analogues by 5-phosphatase.
    Van Dijken P; Lammers AA; Ozaki S; Potter BV; Erneux C; Van Haastert PJ
    Eur J Biochem; 1994 Dec; 226(2):561-6. PubMed ID: 8001571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the enantiomers of 6-deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, structural analogues of myo-inositol 1,3,4,5-tetrakisphosphate.
    Horne G; Potter BV
    Chemistry; 2001 Jan; 7(1):80-7. PubMed ID: 11205029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV
    J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
    Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
    J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
    Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S
    Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential stereoselectivity of D- and L-myo-inositol 1,2,4, 5-tetrakisphosphate binding to the inositol 1,4,5-trisphosphate receptor and 3-kinase.
    Suh BC; Kim MJ; Choi G; Choi KY; Han JK; Chung SK; Kim KT
    Neurochem Int; 2000 Jul; 37(1):47-52. PubMed ID: 10781844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. scyllo-inositol pentakisphosphate as an analogue of myo-inositol 1,3,4,5,6-pentakisphosphate: chemical synthesis, physicochemistry and biological applications.
    Riley AM; Trusselle M; Kuad P; Borkovec M; Cho J; Choi JH; Qian X; Shears SB; Spiess B; Potter BV
    Chembiochem; 2006 Jul; 7(7):1114-22. PubMed ID: 16755629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of D- and L-myo-inositol 1,2,4,6-tetrakisphosphate, regioisomers of myo-inositol 1,3,4,5 tetrakisphosphate: activity against Ins(1,4,5)P3 binding proteins.
    Mills SJ; Backers K; Erneux C; Potter BV
    Org Biomol Chem; 2003 Oct; 1(20):3546-56. PubMed ID: 14599016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of phosphorofluoridate analogues of D-myo-inositol 1,4,5-trisphosphate to assess the involvement of ionic interactions in its recognition by the receptor and metabolising enzymes.
    Yoshimura K; Watanabe Y; Erneux C; Hirata M
    Cell Signal; 1999 Feb; 11(2):117-25. PubMed ID: 10048789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of biotinylated inositol 1,3,4,5-tetrakisphosphate targeting Grp1 pleckstrin homology domain.
    Anraku K; Inoue T; Sugimoto K; Kudo K; Okamoto Y; Morii T; Mori Y; Otsuka M
    Bioorg Med Chem; 2011 Nov; 19(22):6833-41. PubMed ID: 21996606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of potent Ins(1,4,5)P3 5-phosphatase inhibitors by modification of myo-inositol 1,3,4,6-tetrakisphosphate.
    Mills SJ; Potter BV
    Bioorg Med Chem; 2003 Sep; 11(19):4245-53. PubMed ID: 12951155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second messenger specificity of the inositol trisphosphate receptor: reappraisal based on novel inositol phosphates.
    DeLisle S; Radenberg T; Wintermantel MR; Tietz C; Parys JB; Pittet D; Welsh MJ; Mayr GW
    Am J Physiol; 1994 Feb; 266(2 Pt 1):C429-36. PubMed ID: 8141257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Murphy CT; Riley AM; Mills SJ; Lindley CJ; Potter BV; Westwick J
    Mol Pharmacol; 2000 Mar; 57(3):595-601. PubMed ID: 10692501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of D-myo-inositol (1,4,5)/(1,3,4,5)- polyphosphate 5-phosphatase from skeletal muscle.
    Hansbro PM; Foster PS; Hogan SP; Ozaki S; Denborough MA
    Arch Biochem Biophys; 1994 May; 311(1):47-54. PubMed ID: 8185320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Deoxy derivative is a partial agonist of the intracellular messenger inositol 3,4,5,6-tetrakisphosphate in the epithelial cell line T84.
    Rudolf MT; Li WH; Wolfson N; Traynor-Kaplan AE; Schultz C
    J Med Chem; 1998 Sep; 41(19):3635-44. PubMed ID: 9733488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.